Williamson Z Bradford from Palo Alto, CA

view source

Specialties:

Internal Medicine
Infectious Disease

Education:

University of North Carolina (1990)

Macrocyclic Inhibitors Of Hepatitis C Virus Replication
view source
US Patent:

8048862, Nov 1, 2011
Filed:

Apr 14, 2009
Appl. No.:

12/423681
Inventors:

Scott D. Seiwert - Pacifica CA, US
Leonid Beigelman - San Mateo CA, US
Brad Buckman - Oakland CA, US
Antitsa Dimitrova Stoycheva - Half Moon Bay CA, US
Steven B. Porter - Mill Valley CA, US
Williamson Ziegler Bradford - Ross CA, US
Vladimir Serebryany - Burlingame CA, US
Assignee:

InterMune, Inc. - Brisbane CA
International Classification:

A61K 38/21
A61K 31/4709
A61K 31/7056
A61K 31/4738
A61K 31/407
A61K 31/4725
A61K 31/517
A61K 31/403
C07D 245/04
C07D 209/02
US Classification:

514 43, 514312, 514285, 514411, 514309, 5142662, 514336, 514365, 514414, 540460, 424 855, 424 857, 548465
Abstract:

The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Interferon Gamma Therapies For Idiopathic Pulmonary Fibrosis
view source
US Patent:

20070160580, Jul 12, 2007
Filed:

May 13, 2004
Appl. No.:

10/556487
Inventors:

Williamson Bradford - Brisbane CA, US
International Classification:

A61K 38/21
US Classification:

424085600
Abstract:

The present invention provides methods of treating idiopathic pulmonary fibrosis (IPF); methods of increasing survival time in an individual with IPF; and methods of reducing risk of death in an individual with IPF. The methods generally involve administering a therapeutically effective amount of IFN-&ggr, to an individual with IPF.

Marketing System For Improving Patient Compliance And Methods And Devices Relating To Same
view source
US Patent:

20080102056, May 1, 2008
Filed:

Feb 2, 2004
Appl. No.:

10/543466
Inventors:

Williamson Ziegler Bradford - San Francisco CA, US
James Pennington - Lafayette CA, US
Stephen Rosenfield - San Francisco CA, US
Assignee:

INTERMUNE, INC. - Brisbane CA
International Classification:

A61K 38/21
G06Q 50/00
A61P 11/00
A61M 5/14
G06Q 30/00
US Classification:

424 855, 705 14, 6048911, 604502, 604181
Abstract:

The present invention provides a marketing system and methods for marketing a dosage form comprising interferon gamma (IFN-γ) to a patient in need thereof, for the treatment of idiopathic pulmonary fibrosis (IPF). The present invention further provides a method for increasing patient compliance. The present invention further provides methods of treatment and dosage forms compatible for use in the marketing systems and methods of the invention.

Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
view source
US Patent:

20110059047, Mar 10, 2011
Filed:

Nov 18, 2010
Appl. No.:

12/949700
Inventors:

Scott D. Seiwert - Pacifica CA, US
Leonid Beigelman - San Mateo CA, US
Brad Buckman - Oakland CA, US
Antitsa Dimitrova Stoycheva - Half Moon Bay CA, US
Steven B. Porter - Mill Valley CA, US
Williamson Ziegler Bradford - Ross CA, US
Vladimir Serebryany - Burlingame CA, US
Assignee:

InterMune, Inc. - Brisbane CA
International Classification:

A61K 38/12
C07K 5/12
A61K 38/21
A61P 31/14
US Classification:

424 857, 530323, 514 211, 514 43, 424 854
Abstract:

The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Methods Of Diagnosing And Treating Idiopathic Pulmonary Fibrosis
view source
US Patent:

20130150426, Jun 13, 2013
Filed:

Nov 21, 2012
Appl. No.:

13/683099
Inventors:

SHARLENE LIM - SAN MATEO CA, US
XIAOLI QIN - SAN MATEO CA, US
WILLIAMSON ZIEGLER BRADFORD - ROSS CA, US
SCOTT D. SEIWERT - PACIFICA CA, US
Assignee:

INTERMUNE, INC. - BRISBANE CA
International Classification:

C12Q 1/68
US Classification:

514 44 A, 506 9, 536 2431, 536 2433, 514345
Abstract:

Described herein are materials and methods for the diagnosis of idiopathic pulmonary fibrosis.

Williamson Z Bradford